3r1n
From Proteopedia
(Difference between revisions)
m (Protected "3r1n" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | + | [[Image:3r1n.jpg|left|200px]] | |
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_3r1n", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_3r1n| PDB=3r1n | SCENE= }} | ||
| - | + | ===MK3 kinase bound to Compound 5b=== | |
| - | + | ||
| + | <!-- | ||
| + | The line below this paragraph, {{ABSTRACT_PUBMED_21565500}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 21565500 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_21565500}} | ||
| + | |||
| + | ==About this Structure== | ||
| + | [[3r1n]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3R1N OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:021565500</ref><references group="xtra"/> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Non-specific serine/threonine protein kinase]] | ||
| + | [[Category: Kazemier, B.]] | ||
| + | [[Category: Oubrie, A.]] | ||
Revision as of 05:38, 25 May 2011
MK3 kinase bound to Compound 5b
Template:ABSTRACT PUBMED 21565500
About this Structure
3r1n is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Barf T, Kaptein A, Wilde SD, Heijden RV, Someren RV, Demont D, Schultz-Fademrecht C, Versteegh J, Zeeland MV, Seegers N, Kazemier B, Kar BV, Hoek MV, Roos JD, Klop H, Smeets R, Hofstra C, Hornberg J, Oubrie A. Structure-based lead identification of ATP-competitive MK2 inhibitors. Bioorg Med Chem Lett. 2011 Apr 16. PMID:21565500 doi:10.1016/j.bmcl.2011.04.018
